Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001209191-23-045192

Chief Financial Officer gave up 834 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jorgensen Nathan D. Chief Financial Officer 2023-08-07 Shares withheld for taxes −834 $2.67 $2,227 152,791 D
Loading xslF345X05/doc4.xml…